Synthesis and biological activity of new 2-nitroimidazole derivatives. 1978

B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena

In an earlier paper we described the synthesis and the antitrichomonas activity of 2-nitro-alpha,alpha,1-trimethyl-1H-imidazole-5-methanol (2). Starting from this compound, several derivatives have been synthesized. Among these, the phenyl carbonate 8 has been shown to possess activity equal to that of 2 and to be less toxic. This compound therefore is interesting in comparison with some antitrichomonas agents currently in use clinically. Before undertaking an in-depth investigation, compound 8 was subjected to some studies to see whether it has any effects on the central nervous system (CNS). Preliminary results show that, at therapeutic doses, it might induce unwanted CNS effects to a lesser degree than metronidazole.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009174 Mycoplasma A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS. Eperythrozoon,Haemobartonella,Mycoplasma putrefaciens,PPLO,Pleuropneumonia-Like Organisms,Pleuropneumonia Like Organisms
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D003016 Clostridium perfringens The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins. Clostridium welchii
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006591 Hexobarbital A barbiturate that is effective as a hypnotic and sedative. Evipan,Hexenal,Hexobarbitone,Sodium Hexobarbital,Hexobarbital, Sodium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000994 Antitrichomonal Agents Agents used to treat trichomonas infections. Antitrichomonal Drugs,Antitrichomonals,Trichomonicides,Agents, Antitrichomonal,Drugs, Antitrichomonal

Related Publications

B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
November 1989, Farmaco (Societa chimica italiana : 1989),
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
September 1969, Journal of medicinal chemistry,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
January 1990, Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986),
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
June 2012, Archiv der Pharmazie,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
January 1967, Antimicrobial agents and chemotherapy,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
October 2007, Chemical biology & drug design,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
October 2003, Archives of pharmacal research,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
June 2002, Archives of pharmacal research,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
January 1965, Antimicrobial agents and chemotherapy,
B Cavalleri, and G Volpe, and V Arioli, and F Pizzocheri, and A Diena
December 2006, Journal of inorganic biochemistry,
Copied contents to your clipboard!